MWA
MUELLER WATER PRODUCTS
NYSEUSDEQUITY
Industrials
DELAYED
Last price
24.94
▼ 0.19 (0.76%)
MARKET · —
Price
Open
25.13
Prev close
25.13
Day high
25.34
Day low
24.93
Volume
540.43K
Market cap
$3.89B
P/E (TTM)
17.69
52W range
22.74 – 31.00
Trailing performance
Returnvs SPY
1W
-2.35%
-1.0%
1M
+0.24%
-3.5%
3M
-0.72%
-3.8%
6M
-16.78%
-27.8%
YTD
+4.70%
-7.6%
1Y
-5.06%
-25.1%
3Y
+82.44%
+8.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$3.89B
Enterprise value$3.85B
Revenue (TTM)$1.48B
Gross profit$563.20M
EBITDA$360.70M
Net income$222.20M
EPS (TTM)$1.41
Free cash flow$130.71M
Total cash$495.30M
Total debt$452.90M
Book value / share$6.85
Shares outstanding156.13M
Float154.79M
Short % of float4.41%
Dividend yield1.12%
Beta (5Y)1.02
Valuation & profitability ratios
Trailing P/E17.69
Forward P/E15.55
PEG ratio1.02
Price / sales—
Price / book3.64
EV / revenue2.60
EV / EBITDA10.68
Gross margin38.07%
Operating margin23.95%
Profit margin15.02%
Return on equity21.68%
Return on assets10.62%
Debt / equity40.42
Current ratio4.64
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $1.43B | $1.31B | $1.28B | $1.25B |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $191.70M | $115.90M | $85.50M | $76.60M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $191.70M | $115.90M | $85.50M | $76.60M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.39 | 0.50 | +27.4% |
| Mar 2026 | 0.37 | 0.40 | +7.5% |
| Dec 2025 | 0.26 | 0.29 | +10.1% |
| Sep 2025 | 0.34 | 0.38 | +12.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.38 | 5 | $376.63M | -1.1% |
| Next quarter | 0.30 | 5 | $328.43M | +3.2% |
| Current year | 1.57 | 5 | $1.48B | +3.2% |
| Next year | 1.60 | 6 | $1.54B | +4.1% |
Analyst targets & ownership
Mean target$31.00
High target$35.00
Low target$25.00
Implied upside24.30%
Analyst count6
ConsensusBUY
Strong buy / Buy0 / 2
Hold3
Sell / Strong sell0 / 1
Held by insiders1.11%
Held by institutions103.23%
Institutions holding593
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
-77.63K
Net selling
Buy transactions
3
27.35K shares
Sell transactions
3
104.97K shares
Net transactions
+6
Buys less sells
Sell : buy shares
3.8 : 1
Mixed
Insider-held shares
1.73M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | MCANDREW PAUL Chief Executive Officer |
SELL | 40.00K | $1.06M | Direct |
| Jul 7, 26 | HEALY BRIAN C Director |
BUY | 1.18K | $29.96K | Direct |
| May 28, 26 | ZAKAS MARIETTA EDMUNDS Officer and Director |
SELL | 54.25K | $1.37M | Direct |
| May 15, 26 | HEALY BRIAN C Director |
BUY | 1.17K | $30.02K | Direct |
| Mar 17, 26 | HELMS TODD P Officer |
SELL | 10.72K | $295.95K | Direct |
| Feb 25, 26 | SENGSTACK GREGG C Director |
BUY | 25.00K | $739.41K | Direct |
| Feb 19, 26 | HELMS TODD P Officer |
SELL | 10.72K | $318.55K | Direct |
| Feb 10, 26 | MCANDREW PAUL Chief Executive Officer |
STOCK | 20.25K | $0 | Direct |
| Feb 9, 26 | SHARRITTS JEFFERY S. Director |
STOCK | 4.38K | $0 | Direct |
| Jan 7, 26 | HEALY BRIAN C Director |
BUY | 1.13K | $27.46K | Direct |
| Dec 9, 25 | HEINRICHS STEVEN SCOTT Former |
SELL | 33.52K | $814.11K | Direct |
| Dec 4, 25 | HELMS TODD P Officer |
CONVERSION | 20.80K | $254.44K | Direct |
| Dec 4, 25 | HELMS TODD P Officer |
SELL | 15.09K | $371.62K | Direct |
| Dec 2, 25 | ZAKAS MARIETTA EDMUNDS Chief Executive Officer |
STOCK | 20.62K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
FLOYD SCOTT P. |
Officer | 88.11K | Stock Award(Grant) |
FRANKLIN SHIRLEY C |
Former | 65.04K | Sale |
HANSEN THOMAS J |
Director | 86.16K | Sale |
HEALY BRIAN C |
Director | 24.95K | Purchase |
HELMS TODD P |
Officer | 64.48K | Sale |
MCANDREW PAUL |
Chief Executive Officer | 42.56K | Sale |
ORTIZ CHRISTINE |
Director | 38.20K | Sale |
SENGSTACK GREGG C |
Director | 25.00K | Purchase |
THOMAS LYDIA W |
Former | 126.69K | Sale |
ZAKAS MARIETTA EDMUNDS |
Officer and Director | 507.97K | Sale |
Moving averages & technicals
SMA 10
25.50
-2.18% from price
SMA 20
25.70
-2.95% from price
SMA 50
25.56
-2.42% from price
SMA 100
26.26
-5.03% from price
SMA 200
26.31
-5.20% from price
EMA 12
25.44
-1.95% from price
EMA 26
25.53
-2.33% from price
EMA 50
25.66
-2.81% from price
RSI (14)
43.1
Neutral
MACD (12,26,9)
-0.10
Hist -0.13
ATR (14)
0.73
2.91% of price
Realised vol 30D
27.3%
Annualised
Bollinger upper
26.98
20, 2σ
Bollinger lower
24.42
20, 2σ
50 / 200 cross
Death
25.56 vs 26.31
Trend bias
Below 200
-5.20%
Risk profile
Beta vs SPY
0.75
Less volatile than market
Correlation to SPY
0.37
Loosely linked
Realised vol 30D
27.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-19.0%
Peak to trough
Max drawdown 5Y
-42.3%
Peak to trough
ATR 14
0.73
2.91% of price
Beta (reported)
1.02
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.04
Positioning, not flow
Max pain
17.50
-29.8% from spot
ATM implied vol
91.9%
Nearest strike to spot
Skew (10% OTM)
+17.4%
Puts bid over calls
Call volume
13
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
30.00
20 contracts
Heaviest put OI
17.50
1 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Mueller Water Products (MWA) Slid on Broader Investor Concerns
Insider Monkey · 5d ago
2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
StockStory · 6d ago
MWA or NDSN: Which Is the Better Value Stock Right Now?
Zacks · 8d ago
Mueller Water Products (MWA) Q3 2026 Earnings Call Transcript
Motley Fool · 10d ago
3 Reasons Why Growth Investors Shouldn't Overlook Mueller Water Products (MWA)
Zacks · 11d ago
MWA Q2 Deep Dive: Specialty Valves and Margin Gains Offset Residential Weakness
StockStory · 11d ago
Mueller Water Products Inc's Dividend Analysis
GuruFocus.com · 12d ago
Mueller Water Products Q3 Earnings Call Highlights
MarketBeat · 14d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.